Pinnacle Wealth Planning Services’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.52K Hold
8
﹤0.01% 2521
2026
Q1
$1.35K Hold
8
﹤0.01% 2513
2025
Q4
$1.35K Buy
+8
New +$1.3K ﹤0.01% 2550
2021
Q1
Sell
-69
Closed -$10K 1084
2020
Q4
$10K Buy
+69
New +$9.86K ﹤0.01% 1390

Other funds holding IBB

Pinnacle Wealth Planning Services's IBB Position: Q2 2026 in Review

Pinnacle Wealth Planning Services held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 8 shares worth $1.52K. The position accounts for ﹤0.01% of the portfolio, ranked #2521.

Pinnacle Wealth Planning Services first reported a position in IBB in Q4 2020 and has held it in 4 quarters since. The position peaked at $10K in Q4 2020. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Pinnacle Wealth Planning Services held 8 shares of iShares Biotechnology ETF worth $1.52K as of Q2 2026.
  • Pinnacle Wealth Planning Services left its iShares Biotechnology ETF share count unchanged in Q2 2026.
  • iShares Biotechnology ETF made up ﹤0.01% of Pinnacle Wealth Planning Services's portfolio in Q2 2026, its #2521 holding.
  • Pinnacle Wealth Planning Services first reported a position in iShares Biotechnology ETF in Q4 2020 and has held it in 4 quarters since.
  • Pinnacle Wealth Planning Services's iShares Biotechnology ETF position peaked at $10K in Q4 2020.
  • 956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q2 2026, filed 7 Aug 2026.